Additionally, mUNO only targets CD206 in the tumor and not in the liver; a moderate affinity of mUNO for CD206, and a higher dwelling time in tumor than in liver (due to leaky tumor vasculature) may explain this phenomenon (85). This evidence concerns the gene MRC1 and neoplasm.